These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 2780777)

  • 1. The actions of nicotine and cocaine in a mouse model of anxiety.
    Costall B; Kelly ME; Naylor RJ; Onaivi ES
    Pharmacol Biochem Behav; 1989 May; 33(1):197-203. PubMed ID: 2780777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Withdrawal syndrome following subchronic treatment with anxiolytic agents.
    Barry JM; Costall B; Kelly ME; Naylor RJ
    Pharmacol Biochem Behav; 1987 Jun; 27(2):239-45. PubMed ID: 2888134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of ketotifen in rodent models of anxiety and on the behavioural consequences of withdrawing from treatment with drugs of abuse.
    Costall B; Kelly ME; Onaivi ES; Naylor RJ
    Naunyn Schmiedebergs Arch Pharmacol; 1990 Jun; 341(6):547-51. PubMed ID: 2392157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mild anxiogenic effects of nicotine withdrawal in mice.
    Jonkman S; Henry B; Semenova S; Markou A
    Eur J Pharmacol; 2005 May; 516(1):40-5. PubMed ID: 15922326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuropharmacological and physiological validation of a computer-controlled two-compartment black and white box for the assessment of anxiety.
    Onaivi ES; Martin BR
    Prog Neuropsychopharmacol Biol Psychiatry; 1989; 13(6):963-76. PubMed ID: 2573111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ketotifen and its analogues reduce aversive responding in the rodent.
    Barnes NM; Costall B; Kelly ME; Onaivi ES; Naylor RJ
    Pharmacol Biochem Behav; 1990 Dec; 37(4):785-93. PubMed ID: 1965515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The anxiolytic and anxiogenic actions of ethanol in a mouse model.
    Costall B; Kelly ME; Naylor RJ
    J Pharm Pharmacol; 1988 Mar; 40(3):197-202. PubMed ID: 2899150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anxiogenic-like effects limit rewarding effects of cocaine in balb/cbyj mice.
    David V; Gold LH; Koob GF; Cazala P
    Neuropsychopharmacology; 2001 Mar; 24(3):300-18. PubMed ID: 11166520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Profile of action of a novel 5-hydroxytryptamine1A receptor ligand E-4424 to inhibit aversive behavior in the mouse, rat and marmoset.
    Costall B; Domeney AM; Farre AJ; Kelly ME; Martinez L; Naylor RJ
    J Pharmacol Exp Ther; 1992 Jul; 262(1):90-8. PubMed ID: 1352556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Actions of buspirone in a putative model of anxiety in the mouse.
    Costall B; Kelly ME; Naylor RJ; Onaivi ES
    J Pharm Pharmacol; 1988 Jul; 40(7):494-500. PubMed ID: 2904990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Betaxolol, a selective beta(1)-adrenergic receptor antagonist, diminishes anxiety-like behavior during early withdrawal from chronic cocaine administration in rats.
    Rudoy CA; Van Bockstaele EJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun; 31(5):1119-29. PubMed ID: 17513029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of captopril and SQ29,852 on anxiety-related behaviours in rodent and marmoset.
    Costall B; Domeney AM; Gerrard PA; Horovitz ZP; Kelly ME; Naylor RJ; Tomkins DM
    Pharmacol Biochem Behav; 1990 May; 36(1):13-20. PubMed ID: 2112256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protracted withdrawal: sensitization of the anxiogenic response to cocaine in rats concurrently treated with ethanol.
    Prather PL; Lal H
    Neuropsychopharmacology; 1992 Jan; 6(1):23-9. PubMed ID: 1571066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ondansetron inhibits a behavioural consequence of withdrawing from drugs of abuse.
    Costall B; Jones BJ; Kelly ME; Naylor RJ; Onaivi ES; Tyers MB
    Pharmacol Biochem Behav; 1990 Jun; 36(2):339-44. PubMed ID: 2141423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploration of mice in a black and white test box: validation as a model of anxiety.
    Costall B; Jones BJ; Kelly ME; Naylor RJ; Tomkins DM
    Pharmacol Biochem Behav; 1989 Mar; 32(3):777-85. PubMed ID: 2740429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence of cross-tolerance between behavioural effects of nicotine and cocaine in mice.
    Desai RI; Terry P
    Psychopharmacology (Berl); 2003 Mar; 166(2):111-9. PubMed ID: 12545328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anxiety-like behavior during nicotine withdrawal predict subsequent nicotine consumption in adolescent C57BL/6 mice.
    Manhães AC; Guthierrez MC; Filgueiras CC; Abreu-Villaça Y
    Behav Brain Res; 2008 Nov; 193(2):216-24. PubMed ID: 18573281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Behavioral effects in the mouse during and following withdrawal from ethanol ingestion and/or nicotine administration.
    Onaivi ES; Todd S; Martin BR
    Drug Alcohol Depend; 1989 Dec; 24(3):205-11. PubMed ID: 2605996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined exposure to nicotine and ethanol in adolescent mice differentially affects anxiety levels during exposure, short-term, and long-term withdrawal.
    Abreu-Villaça Y; Nunes F; do E Queiroz-Gomes F; Manhães AC; Filgueiras CC
    Neuropsychopharmacology; 2008 Feb; 33(3):599-610. PubMed ID: 17460612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective CRF2 receptor agonists ameliorate the anxiety- and depression-like state developed during chronic nicotine treatment and consequent acute withdrawal in mice.
    Bagosi Z; Palotai M; Simon B; Bokor P; Buzás A; Balangó B; Pintér D; Jászberényi M; Csabafi K; Szabó G
    Brain Res; 2016 Dec; 1652():21-29. PubMed ID: 27693397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.